Pain is a universal human experience. The International Association for the Study of Pain (IASP) defines pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage.” Pain may be a symptom of an underlying disease or disorder, or a disorder in its own right.
FDA expands use of Prevnar 13 vaccine for people ages 50 and older – Prevnar 13, a pneumonia vaccine, is approved for people ages 50 years and older to prevent pneumonia and invasive disease caused by the bacterium, Streptococcus pneumoniae.
Knee pain common complaint in middle-aged and mature women — Study finds pain patterns vary over a 12-year period – 63% of women age 50 and older reported persistent, incident, or intermittent knee pain during a 12-year study period, revealed by researchers. Predictors for persistent pain included higher body mass index (BMI), previous knee injury, and radiographic osteoarthritis (OA).
Front Row Produce Recalls Grape Tomatoes Because Of Possible Health Risk – Front Row Produce of St. Louis MO is recalling its 10oz pint and 10lb bulk grape tomatoes supplied by Rio Queen Citrus, Mission TX, because they have the potential to be contaminated with Salmonella.
Exercise helps us to eat a healthy diet – A healthy diet and the right amount of exercise are key players in treating and preventing obesity but we still know little about the relationship both factors have with each other. A new study now reveals that an increase in physical activity is linked to an improvement in diet quality.
Dreaming takes the sting out of painful memories — UC Berkeley researchers have found that stress chemicals shut down and the brain processes emotional experiences during the REM dream phase of sleep – During the dream phase of sleep, also known as REM sleep, our stress chemistry shuts down and the brain processes emotional experiences and takes the painful edge off difficult memories. Time spent in dream sleep can help.
Regeneron Announces FDA Approval of EYLEA? (Aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration – The U.S. Food and Drug Administration approved Eylea (aflibercept) to treat patients with wet (neovascular) age-related macular degeneration (AMD), a leading cause of vision loss and blindness in Americans ages 60 and older.
Poor sleep habits linked to increased risk of fibromyalgia in women — Middle-aged and older women with sleep problems are at greater risk – Researchers from Norway have uncovered an association between sleep problems and increased risk of fibromyalgia in women. The risk of fibromyalgia increased with severity of sleep problems, and the association was stronger among middle-aged and older women than among younger women.
Pfizer new drug BZA/CE could provide a new treatment option for symptomatic postmenopausal women with a uterus – Pfizer Inc. will announce new one-year results from the Selective estrogens, Menopause, And Response to Therapy [SMART]-5 Phase 3 study of the safety and efficacy of the investigational tissue selective estrogen complex (TSEC) bazedoxifene/conjugated estrogens (BZA/CE) at the 22nd annual meeting of the North American Menopause Society (NAMS), September_21-24 in Washington, D.C.
FDA approves Remicade to treat ulcerative colitis in children older than 6 years – The U.S. Food and Drug Administration approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children older than 6 years who have had inadequate response to conventional therapy.
Study shows intrauterine devices may lower risk for developing cervical cancer – IUDs or intrauterine contraceptive devices could substantially reduce the risk of women developing cervical cancer, revealed by researchers in a recent study in Lancet Oncology.
Osteoporosis drugs need better labels indicating time limits, suggested by FDA panel, but how much time is yet to be determined – A US FDA advisory committee wants the health agency FDA to limit the duration of bisphosphonate therapy for treatment of osteoporosis. The panel could not agree on what that time limit should be. The panel also endorsed a label change for osteoporosis drugs.
FDA approves the first specific treatment for scorpion stings – The U.S. Food and Drug Administration approved Anascorp, the first specific treatment for a scorpion sting by Centruroides scorpions in the United States.
